Research Paper Volume 15, Issue 16 pp 8204—8219
PTPRD mutation is a prognostic biomarker for sensitivity to ICIs treatment in advanced non-small cell lung cancer
Figure 2. Enrichment analysis and PPI network construction. (A) GO analysis. (B) KEGG analysis.